Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia
S R Nussbaum, R P Warrell, R Rude, et al.
Cancer Research
|
December 1, 1995
Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias
J G Jurcic, P C Caron, T K Nikula, et al.
The New England Journal of Medicine
|
April 19, 1990
Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer
W J Burtis, T G Brady, J J Orloff, et al.
The New England Journal of Medicine
|
November 5, 1998
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
S L Soignet, P Maslak, Z G Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
V A Miller, F M Benedetti, J R Rigas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid
V A Miller, J R Rigas, F M Benedetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
S L Soignet, S R Frankel, D Douer, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia
S R Nussbaum, R P Warrell, R Rude, et al.
Cancer Research
|
December 1, 1995
Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias
J G Jurcic, P C Caron, T K Nikula, et al.
The New England Journal of Medicine
|
April 19, 1990
Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer
W J Burtis, T G Brady, J J Orloff, et al.
The New England Journal of Medicine
|
November 5, 1998
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
S L Soignet, P Maslak, Z G Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
V A Miller, F M Benedetti, J R Rigas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid
V A Miller, J R Rigas, F M Benedetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
S L Soignet, S R Frankel, D Douer, et al.
Page
of 12